![An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials | npj Digital Medicine An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials | npj Digital Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41746-023-00963-z/MediaObjects/41746_2023_963_Fig1_HTML.png)
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials | npj Digital Medicine
![Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery | Nature Medicine Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01681-x/MediaObjects/41591_2022_1681_Fig1_HTML.png)
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery | Nature Medicine
![Conducting a clinical trial? 3 Kinds of statistical analysis you need to generate high-quality evidence | Editage Insights Conducting a clinical trial? 3 Kinds of statistical analysis you need to generate high-quality evidence | Editage Insights](https://insights.cactusglobal.com/sites/default/files/Ad%20Banners_Insights_656x250_02_0.png)
Conducting a clinical trial? 3 Kinds of statistical analysis you need to generate high-quality evidence | Editage Insights
![Donanemab Treatment Effects in Early Stages of Alzheimer Disease Detailed in New Post-Hoc Analysis from TRAILBLAZER-ALZ 2 - Practical Neurology Donanemab Treatment Effects in Early Stages of Alzheimer Disease Detailed in New Post-Hoc Analysis from TRAILBLAZER-ALZ 2 - Practical Neurology](https://core4.bmctoday.net/storage/images/Screenshot%202023-10-25%20at%2010.26.34%20AM_1698244057.png)
Donanemab Treatment Effects in Early Stages of Alzheimer Disease Detailed in New Post-Hoc Analysis from TRAILBLAZER-ALZ 2 - Practical Neurology
![Adaptive designs in clinical trials: why use them, and how to run and report them | BMC Medicine | Full Text Adaptive designs in clinical trials: why use them, and how to run and report them | BMC Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12916-018-1017-7/MediaObjects/12916_2018_1017_Fig1_HTML.gif)
Adaptive designs in clinical trials: why use them, and how to run and report them | BMC Medicine | Full Text
![JPM | Free Full-Text | Management of Onsite and Remote Communication in Oncology Hospitals: Data Protection in an Era of Rapid Technological Advances JPM | Free Full-Text | Management of Onsite and Remote Communication in Oncology Hospitals: Data Protection in an Era of Rapid Technological Advances](https://www.mdpi.com/jpm/jpm-13-00761/article_deploy/html/images/jpm-13-00761-g001.png)
JPM | Free Full-Text | Management of Onsite and Remote Communication in Oncology Hospitals: Data Protection in an Era of Rapid Technological Advances
![Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/b83761f2-9ba7-4c94-ad8d-c91279061c89/gr1.jpg)